<p>Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers</p>

Abstract

Intraperitoneal administration of Res effectively inhibited rat orthotopic ovarian cancer growth without affecting normal tissues. The Res-in-DMSO group had the highest drug bioavailability and therefore stronger tumor-suppressive effects on ovarian cancer tissues.